Overview
These four names get used interchangeably and they are not the same thing. They are different points on one pathway, and where a compound enters that pathway is what distinguishes it.
NAD+ is the destination. The others are ways of getting there.
| Compound | What it is | Where it enters | Notes |
|---|---|---|---|
| Niacin (nicotinic acid) | A form of vitamin B3 | Via the Preiss-Handler pathway | Causes flushing at higher intakes. Also an approved lipid drug at prescription strengths |
| Nicotinamide (niacinamide) | The other form of vitamin B3 | Directly into the salvage pathway | No flushing. The form in most B-complex products |
| NR (nicotinamide riboside) | A precursor, one step further along | Converted to NMN, then NAD+ | Sold as a dietary supplement. Best-documented for raising NAD+ metabolites in humans |
| NMN (nicotinamide mononucleotide) | A precursor, one step from NAD+ | Directly converted to NAD+ | Contested regulatory status in the US |
| NAD+ | The active coenzyme | — | Not absorbed intact by mouth |
The single most useful fact here: you cannot take NAD+ orally and have it arrive as NAD+. It is broken down in the digestive tract. Every oral product is delivering a precursor, whatever the label says — which is why the distinctions between the precursors are the ones that actually matter.
The pathway, briefly
Your body maintains its NAD+ pool through three routes, and knowing which is which explains everything else.
The salvage pathway does most of the work. NAD+ that has been broken down releases nicotinamide, which is recaptured and rebuilt into NAD+ via NMN. This recycling accounts for the majority of NAD+ maintenance, and its rate-limiting enzyme is NAMPT.
The Preiss-Handler pathway takes niacin (nicotinic acid) from the diet and converts it through several steps.
The de novo pathway builds NAD+ from tryptophan, an amino acid in protein foods. It works, and it is inefficient — a large amount of tryptophan yields a small amount of NAD+.
Precursor supplements are essentially different entry points into these routes. NR and NMN enter close to the end; niacin and nicotinamide enter further back.
Niacin versus nicotinamide, which trips everyone up
Both are vitamin B3, and they behave quite differently.
Niacin (nicotinic acid) causes the well-known flush — warmth, redness and tingling across the face and chest, appearing within minutes of a higher intake and lasting up to an hour or so. It is prostaglandin-mediated, harmless, and unpleasant enough that many people stop taking it. Extended-release preparations reduce it.
Niacin is also, at prescription strengths, an approved medication for lipid disorders — one of the clearest examples of the same molecule occupying two regulatory categories depending on strength and purpose. At those strengths it requires medical supervision, including monitoring of liver function and glucose.
Nicotinamide (niacinamide) does not cause flushing and does not have the lipid effects. It enters the salvage pathway directly. It is the form in most B-complex supplements and in a great many skincare products.
They are not interchangeable, and a product labeled "vitamin B3" may be either.
NR and NMN
These are the two compounds the NAD+ supplement market is built on, and they sit one step apart.
NR (nicotinamide riboside) is converted into NMN, then into NAD+. It has the more developed human dataset of the two — multiple human trials have shown it raises blood NAD+ metabolite levels, a finding that has replicated consistently, and it has been generally well tolerated in those studies. Whether it produces functional benefits is the subject of ongoing research.
NMN (nicotinamide mononucleotide) sits one step closer to NAD+. A long-running question in the field has been whether NMN is taken up by cells directly or is first converted to NR at the cell surface — a technical point that has been actively debated and does not have a settled answer.
NMN's regulatory position in the United States is the practical complication. The FDA has taken the view that NMN is excluded from the dietary supplement definition, on the basis that it was authorized for investigation as a new drug before being marketed as a supplement. That position has been disputed by the supplement industry and has affected availability. More on how the categories work.
Why oral NAD+ is a misnomer
NAD+ itself is a dinucleotide — too large to be absorbed intact across the intestinal wall. Digestive enzymes break it down into its components before absorption.
So a capsule labeled "NAD+" delivers breakdown products, which function as inefficient precursors. It is not delivering NAD+ to your cells, whatever the front of the bottle says.
This is the reason NAD+ is given by injection or infusion when the intention is to deliver NAD+ itself — the route bypasses the digestive step entirely. How the two approaches compare.
Which one people actually choose
Practically, the decision usually comes down to a few things.
Cost, which differs substantially between them — niacin and nicotinamide are inexpensive vitamins, NR and NMN considerably less so.
Tolerance of flushing, which rules out immediate-release niacin for many people.
Availability, which is where NMN's regulatory position becomes a practical issue rather than a theoretical one.
How much human data matters to you, which currently favors NR among the newer precursors.
And what else you are doing — worth remembering that exercise, sleep and alcohol affect NAD+ metabolism through mechanisms none of these compounds touch.
Frequently asked questions
Is vitamin B3 the same as NAD+? No. Vitamin B3 — as niacin or nicotinamide — is a precursor the body converts into NAD+ through several steps. NAD+ is the active coenzyme.
What is the difference between niacin and nicotinamide? Niacin causes flushing and has lipid effects, and at prescription strengths is an approved lipid medication. Nicotinamide does not flush and has no lipid effect. Both are vitamin B3.
Is NMN better than NR? NMN sits one step closer to NAD+ in the pathway; NR has the more developed human dataset. Whether cellular uptake differs meaningfully between them is still debated, and NMN's US regulatory position is contested.
Can I just take NAD+ in a capsule? Not effectively. NAD+ is broken down in the digestive tract rather than absorbed intact, so oral products deliver precursors regardless of the label.
Is cheap niacin as good as an NAD+ supplement? Niacin is a genuine precursor and inexpensive. It enters the pathway at a different point and causes flushing at higher intakes. The compounds are not equivalent, and which is appropriate depends on what you are trying to do.
Where this fits in your plan
Most of the confusion in this category dissolves once you can see that these are points on one pathway rather than competing products.
Which one is worth taking, if any, depends on what you are addressing — and that is a more useful conversation after a panel than before one. What we check, and what NAD+ therapy involves here.
We measure first. Then we act.
Ready to start your second act?
It starts with measuring, not guessing. A short, clinician-reviewed assessment shows what fits you.
This article is educational and is not medical advice. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. Individual results vary.
